Bayer‘s Board of Management presents its 2023 financial results and an update on company direction.

0:00 Introduction – Michael Preuss
0:57 Enhance Performance and Regain Flexibility – Bill Anderson
23:13 Enabling DSO Through Organizational Design – Heike Prinz
30:41 Financial Results 2023 – Wolfgang Nickl
37:46 Crop Science Divisional Performance 2023 – Rodrigo Santos
41:41 Crop Science Outlook for 2024 – Rodrigo Santos
42:12 Pharma Divisional Performance 2023 – Stefan Oelrich
46:14 Pharma Outlook for 2024 – Stefan Oelrich
46:52 Consumer Health Divisional Performance 2023 – Heiko Schipper
49:11 Consumer Health Outlook for 2024 – Heiko Schipper

свернуть